Akebia Therapeutics Inc. (AKBA) Surged To An 8-Month High On License Agreement

Akebia Therapeutics Inc. (AKBA) announced Tuesday morning that it has entered into a collaboration and license agreement with Otsuka Pharmaceutical to develop and commercialize vadadustat in the U.S.

from RTT - Before the Bell http://ift.tt/2i0fSRm
via IFTTT